Understanding Heart Failure
Prevalence and Impact
Heart failure is a global health issue, affecting over 23 million individuals worldwide. Despite advancements in both diagnosis and treatment, the five-year mortality rate for patients with heart failure remains alarmingly high, ranging from 45% to 60%.
What is Heart Failure?
Heart failure occurs when the heart becomes damaged or weakened, impairing its ability to pump blood effectively throughout the body. The primary causes of heart failure include heart attacks (myocardial infarctions) and high blood pressure (hypertension). Other contributing factors may include diabetes, high blood cholesterol, excessive alcohol or drug use, thyroid disorders, and heart valve diseases.
Strategies for Preventing and Treating Heart Failure
Rising Susceptibility
As survival rates from heart attacks improve, the number of individuals vulnerable to heart failure is increasing. Given the seriousness of this condition and the absence of a cure, research focused on identifying potential therapeutic targets is imperative. One such target is the β3-adrenergic receptor (β3-AR), which plays a crucial role in regulating heart function under stress conditions. This receptor impacts muscle contraction, alleviating the heart’s workload by reducing the rate and strength of heartbeats.
Lifestyle Medicine
Lifestyle changes are essential in the management of heart failure. Regular exercise offers numerous cardiovascular benefits, including a reduction in heart disease incidence. For patients with stable heart failure, exercise can alleviate symptoms, enhance quality of life, and lower mortality risk.
The Role of Nitric Oxide in Exercise
Nitric Oxide Synthase and Heart Protection
Nitric oxide synthase (NOS) and nitric oxide (NO) are significant in the heart’s protective response to exercise, although the underlying mechanisms remain unclear. Previous research has indicated that β3-ARs are linked to the activation of NO/NOS, which tends to increase during physical activity. A recent study by Wang and colleagues in PLOS ONE proposed that the β3-ARs-NO-NOS pathway is engaged during aerobic exercise, offering protection against heart failure and cardiac hypertrophy (the thickening of heart muscle walls).
Inhibition Mechanisms
In a mouse model of heart failure, subjects underwent moderate aerobic exercise (swimming for nine weeks) along with treatment using a β3-AR specific inhibitor. Mice that exercised exhibited improved left ventricular function and reduced hypertrophy. However, administration of the β3-AR inhibitor negated the activation of NOS/NO, diminishing the protective effects against heart failure and hypertrophy. Additionally, reduced NO production resulted in increased levels of reactive oxygen species (ROS), which can contribute to oxidative stress and damage.
Implications for Heart Health
Importance of β3-AR Stimulation
These findings indicate that stimulation of β3-ARs is necessary for achieving cardioprotective effects, attributed to the balance between NO and ROS production. Exercise plays a vital role in maintaining this equilibrium. Consequently, the protective mechanisms observed—such as enhanced heart function and reduced dilation of the left ventricular chamber and hypertrophy—could be linked to the activation of the β3-ARs-NO-NOS pathway. This research supports the notion that β3-ARs represent promising therapeutic targets for treating heart diseases, including heart failure. Furthermore, it underscores the critical importance of aerobic exercise in promoting heart health, especially for those diagnosed with heart failure.
References
Wang B, Xu M, Li W, Li X, Zheng Q, et al. (2017). Aerobic exercise protects against pressure overload-induced cardiac dysfunction and hypertrophy via β3-AR-nNOS-NO activation. PLOS ONE 12(6): e0179648. https://doi.org/10.1371/journal.pone.0179648
Heart failure. Heart and Stroke Foundation of Canada. Accessed June 23, 2017. https://www.heartandstroke.ca/heart-disease/conditions/heart-failure.